SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 7,786.05 |
Enterprise Value ($M) | 7,452.50 |
Book Value ($M) | 2,078.15 |
Book Value / Share | 11.18 |
Price / Book | 3.75 |
NCAV ($M) | 1,847.38 |
NCAV / Share | 9.94 |
Price / NCAV | 4.21 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.32 |
Return on Assets (ROA) | -0.37 |
Return on Equity (ROE) | -0.40 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 13.46 |
Current Ratio | 13.46 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2,134.58 |
Assets | 2,365.35 |
Liabilities | 287.20 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -689.52 |
Net Income | -600.09 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -557.44 |
Cash from Investing | -554.39 |
Cash from Financing | 959.41 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Janus Henderson Group Plc | 5.20 | ||
13G/A | Wellington Management Group Llp | 6.83 | -23.39 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
818,999 | 4,104,212 | 19.96 | |
417,797 | 1,891,566 | 22.09 | |
863,659 | 2,713,802 | 31.82 | |
306,431 | 1,029,217 | 29.77 | |
(click for more detail) |
Similar Companies | |
---|---|
ROIV – Roivant Sciences Ltd. | RPRX – Royalty Pharma plc |
RPTX – Repare Therapeutics Inc. | RXRX – Recursion Pharmaceuticals, Inc. |
SANA – Sana Biotechnology, Inc. |
Financial data and stock pages provided by
Fintel.io